Literature DB >> 22664356

Production of hepatitis B defective particles is dependent on liver status.

Francois Redelsperger1, Bouchra Lekbaby, Yassmina Mandouri, Eric Giang, Marion Duriez, Nathalie Desire, Anne-Marie Roque Afonso, Segolene Brichler, Pascal Dubreuil, Anca Dobrin, Gabriel Perlemuter, Sophie Prevot, Nathalie Bacon, Jean Didier Grange, Fadila Zatla, Catherine Le Pendeven, Stanislas Pol, Helene Strick-Marchand, James Di Santo, Dina Kremsdorf, Patrick Soussan.   

Abstract

Defective hepatitis B virus (dHBV) generated from spliced RNA is detected in the sera of HBV-chronic carriers. Our study was designed to determine whether the proportion of dHBV changed during the course of infection, and to investigate whether dHBV might interfere with HBV replication. To achieve this, HBV wild-type and dHBV levels were determined by Q-PCR in sera from 56 untreated chronic patients and 23 acute patients, in sequential samples from 4 treated-patients and from liver-humanized mice after HBV infection. The proportion of dHBV was higher in patients with severe compared to null/moderate liver disease or with acute infection. Follow-up showed that the proportion of dHBV increased during disease progression. By contrast, a low and stable proportion of dHBV was observed in the humanized-mouse model of HBV infection. Our results highlight a regulation of the proportion of dHBV during liver disease progression that is independent of interference with viral replication.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22664356     DOI: 10.1016/j.virol.2012.05.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

2.  Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle.

Authors:  Aurélie Schnuriger; Patrick Soussan; Jules Sotty; Pierre Bablon; Bouchra Lekbaby; Jérémy Augustin; Morgane Girier-Dufournier; Lucas Langlois; Céline Dorival; Fabrice Carrat; Stanislas Pol; Hélène Fontaine; Nazim Sarica; Christine Neuveut; Chantal Housset; Dina Kremdsorf
Journal:  Hepatol Int       Date:  2022-08-04       Impact factor: 9.029

3.  Alternative splicing of hepatitis B virus: A novel virus/host interaction altering liver immunity.

Authors:  Marion Duriez; Yassmina Mandouri; Bouchra Lekbaby; Hualin Wang; Aurélie Schnuriger; Francois Redelsperger; Chiara Ida Guerrera; Marine Lefevre; Veronique Fauveau; James Ahodantin; Ivan Quetier; Cerina Chhuon; Samir Gourari; Alexandre Boissonnas; Upkar Gill; Patrick Kennedy; Nabil Debzi; Delphine Sitterlin; Mala K Maini; Dina Kremsdorf; Patrick Soussan
Journal:  J Hepatol       Date:  2017-06-07       Impact factor: 25.083

Review 4.  Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

Authors:  Peter A Revill; Capucine Penicaud; Christian Brechot; Fabien Zoulim
Journal:  Genes (Basel)       Date:  2019-04-01       Impact factor: 4.096

5.  Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production.

Authors:  Hélène Chabrolles; Héloïse Auclair; Serena Vegna; Thomas Lahlali; Caroline Pons; Maud Michelet; Yohann Couté; Lucid Belmudes; Gilliane Chadeuf; Yujin Kim; Ariel Di Bernardo; Pascal Jalaguier; François-Loïc Cosset; Floriane Fusil; Michel Rivoire; Lee D Arnold; Uri Lopatin; Christophe Combet; Fabien Zoulim; David Grierson; Benoit Chabot; Julie Lucifora; David Durantel; Anna Salvetti
Journal:  PLoS Pathog       Date:  2020-11-12       Impact factor: 6.823

6.  More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication.

Authors:  Ka-Cheung Luk; Jeffrey Gersch; Barbara J Harris; Vera Holzmayer; Dora Mbanya; Silvia Sauleda; Mary A Rodgers; Gavin Cloherty
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

7.  Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection.

Authors:  Olivia Maslac; Josef Wagner; Vitina Sozzi; Hugh Mason; Jenny Svarovskaia; Susanna Tan; Anuj Gaggar; Stephen Locarnini; Lilly Yuen; Margaret Littlejohn; Peter A Revill
Journal:  J Viral Hepat       Date:  2022-05-28       Impact factor: 3.517

8.  Hepatitis B virus spliced variants are associated with an impaired response to interferon therapy.

Authors:  Jieliang Chen; Min Wu; Fan Wang; Wen Zhang; Wei Wang; Xiaonan Zhang; Jiming Zhang; Yinghui Liu; Yi Liu; Yanling Feng; Ye Zheng; Yunwen Hu; Zhenghong Yuan
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.